News
AstraZeneca kidney inflammation treatment trial reaches dosing stage
Following its phase 2 proof of concept trial, Saphnelo – also know as anifrolumab – has been provided to patients as part of the critical IRIS phase 3 clinical trial to treat lupus nephritis (LN).